Skip to Content

Allon Therapeutics Inc - Stock Quote NPCUF

Rating as of

Morningstar's Allon Therapeutics Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - NPCUF

Allon Therapeutics Inc's Company Profile

Business Description

Allon Therapeutics Inc is engaged in the development and commercialization of central nervous system drugs.

1168 Hamilton Street, Suite 506
Vancouver, BC, V6B 2S2, Canada
T +1 604 736-0634
Industry Biotechnology
Most Recent Earnings Mar 31, 2013
Fiscal Year End Dec 31, 2013
Stock Type
Employees 8